Shopping Cart
Remove All
  • TargetMol
    Your shopping cart is currently empty

Anti-OX40/TNFRSF4 Antibody-FITC (2E203) (Synonyms: TXGP1L, tumor necrosis factor receptor superfamily, member 4...)

Catalog No. TMAY-00885F Copy Product Info
🥰Excellent
Anti-OX40/TNFRSF4 Antibody-FITC (2E203) is a FITC-conjugated Mouse antibody targeting OX40/TNFRSF4. Anti-OX40/TNFRSF4 Antibody-FITC (2E203) can be used in FCM.

Anti-OX40/TNFRSF4 Antibody-FITC (2E203)

Copy Product Info
🥰Excellent
Catalog No. TMAY-00885F
Synonyms TXGP1L, tumor necrosis factor receptor superfamily, member 4, OX40, IMD16, CD134, ACT35

Anti-OX40/TNFRSF4 Antibody-FITC (2E203) is a FITC-conjugated Mouse antibody targeting OX40/TNFRSF4. Anti-OX40/TNFRSF4 Antibody-FITC (2E203) can be used in FCM.

Anti-OX40/TNFRSF4 Antibody-FITC
(2E203)
Pack SizePriceUSA StockGlobal StockQuantity
25 T$817-10 days7-10 days
100 T$1747-10 days7-10 days
For In stock only · Estimated delivery: USA Stock (1-2 days) Global Stock (5-7 days)
Add to Cart
Add to Quotation
For research use only—not for human use. No sales to individuals. Use as intended only.
Questions
TargetMol
View More

Product Introduction

Bioactivity
Description
Anti-OX40/TNFRSF4 Antibody-FITC (2E203) is a FITC-conjugated Mouse antibody targeting OX40/TNFRSF4. Anti-OX40/TNFRSF4 Antibody-FITC (2E203) can be used in FCM.
SynonymsTXGP1L, tumor necrosis factor receptor superfamily, member 4, OX40, IMD16, CD134, ACT35
Ig Type
Mouse IgG1
Clone
2E203
Reactivity
Human
Specificity
Human OX40/TNFRSF4
Verified Activity
Flow cytometric analysis of Human OX40 expression on PHA-activated human whole blood lymphocytes. Cells were stained with FITC-conjugated anti-Human OX40. The fluorescence histograms were derived from gated events with the forward and side light-scatter characteristics of viable lymphocytes.
Application
Recommended Dose
5 μl/Test, 0.1 mg/ml
Antibody Type
Monoclonal
Host SpeciesMouse
ConstructionThis product is a recombinant monoclonal antibody expressed from HEK293 cells, and conjugated with FITC under optimum conditions, the unreacted FITC was removed.
PurificationProtein A
AppearanceLiquid
FormulationPBS solution containing 0.5% BSA and 0.03%ProClin300
Research BackgroundOX40 (CD134) and its binding partner, OX40L (CD252), are members of the tumor necrosis factor receptor/tumor necrosis factor superfamily, is known to break an existing state of tolerance in malignancies, leading to a reactivation of antitumor immunity. The interaction between OX40 and OX40L plays an important role in antigen-specific T-cell expansion and survival. OX40 and OX40L also regulate cytokine production from T cells, antigen-presenting cells, natural killer cells, and natural killer T cells, and modulate cytokine receptor signaling. In line with these important modulatory functions, OX40-OX40L interactions have been found to play a central role in the development of multiple inflammatory and autoimmune diseases, making them attractive candidates for intervention in the clinic. Conversely, stimulating OX40 has shown it to be a candidate for therapeutic immunization strategies for cancer and infectious disease.Cancer ImmunotherapyCo-stimulatory Immune Checkpoint TargetsImmune CheckpointImmune Checkpoint Detection: AntibodiesImmune Checkpoint Detection: ELISA AntibodiesImmune Checkpoint Detection: WB AntibodiesImmune Checkpoint ProteinsImmune Checkpoint TargetsImmunotherapyTargeted Therapy
Related Conjugates and Formulations
Conjucates
FITC
Others Formats
Unconjugated/PE
Antibody Types Available
3
Antigen Details
Immunogen
Recombinant Protein: Human OX40 Protein (TMPY-01423)
Antigen Species
Human
Biology Area
Cancer Drug Targets
Chemical Properties
Stability & Storage
Stability & StorageStore at 2°C-8°C for 12 months, do not freeze. Keep away from direct sunlight.
TransportShipping with blue ice.

Calculator

  • Dilution Calculator
  • Reconstitution Calculator

Keywords

Related Tags: buy Anti-OX40/TNFRSF4 Antibody-FITC (2E203) | purchase Anti-OX40/TNFRSF4 Antibody-FITC (2E203) | Anti-OX40/TNFRSF4 Antibody-FITC (2E203) cost | order Anti-OX40/TNFRSF4 Antibody-FITC (2E203)